drugset / Trial / NCT00193674

Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage

NCT00193674

Phase 3 Completed 71 enrolled Abbott Products
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this clinical study is to demonstrate the shift from inflammatory cytokines to non-inflammatory cytokines in women suffering from habitual abortion treated with dydrogesterone (Duphaston).

Timeline

Start
2003-09
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dydrogesterone Other / unclassified 20 mg Oral